• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
State tobacco lobbyists and organizations in the United States: crossed lines.美国的州烟草游说者和组织:越界了。
Am J Public Health. 1996 Aug;86(8):1137-42. doi: 10.2105/ajph.86.8_pt_1.1137.
2
State legislators' perceptions of lobbyists and lobbying on tobacco control issues.州立法者对说客以及烟草控制问题游说活动的看法。
Tob Control. 1997 Winter;6(4):332-6. doi: 10.1136/tc.6.4.332.
3
How tobacco companies use the revolving door between government and industry to influence policymaking: an Australian case study.烟草公司如何利用政府和行业之间的旋转门来影响决策制定:澳大利亚案例研究。
Public Health Res Pract. 2023 Dec 6;33(4):33122305. doi: 10.17061/phrp33122305.
4
Cannabis industry lobbying in the Colorado state legislature in fiscal years 2010-2021.2010-2021 财年科罗拉多州立法机关的大麻行业游说活动。
Int J Drug Policy. 2022 Apr;102:103585. doi: 10.1016/j.drugpo.2022.103585. Epub 2022 Jan 24.
5
Mapping the Lobbying Footprint of Harmful Industries: 23 Years of Data From OpenSecrets.绘制有害产业的说客活动版图:OpenSecrets 数据库 23 年的数据
Milbank Q. 2024 Mar;102(1):212-232. doi: 10.1111/1468-0009.12686. Epub 2024 Jan 14.
6
Can lobbyists represent tobacco and health?游说者能代表烟草行业和健康吗?
Mod Healthc. 1993 Mar 22;23(12):20.
7
Tobacco Industry Influences in the Oklahoma Legislature.烟草行业对俄克拉荷马州立法机构的影响。
J Okla State Med Assoc. 2015 Nov;108(11):441-9.
8
Lobbying by omission: what is known and unknown about harmful industry lobbyists in Australia.隐瞒式游说:澳大利亚有害行业游说者的已知和未知情况。
Health Promot Int. 2023 Oct 1;38(5). doi: 10.1093/heapro/daad134.
9
Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018.美国制药和保健品行业 1999-2018 年的游说支出和竞选捐款。
JAMA Intern Med. 2020 May 1;180(5):688-697. doi: 10.1001/jamainternmed.2020.0146.
10
Tobacco Institute lobbying at the state and local levels of government in the 1990s.20世纪90年代,烟草协会在州和地方政府层面进行游说活动。
Tob Control. 2002 Mar;11 Suppl 1(Suppl 1):I102-9. doi: 10.1136/tc.11.suppl_1.i102.

引用本文的文献

1
Combatting tobacco industry lobbyists in public health.在公共卫生领域对抗烟草行业的说客。
Tob Induc Dis. 2023 Oct 20;21:137. doi: 10.18332/tid/172140. eCollection 2023.
2
Interest Group Conflict Over Medicaid Expansion: The Surprising Impact of Public Advocates.医疗补助扩大计划中的利益集团冲突:公共倡导者的惊人影响
Am J Public Health. 2016 Feb;106(2):308-13. doi: 10.2105/AJPH.2015.302943. Epub 2015 Dec 21.
3
Development of a model of the tobacco industry's interference with tobacco control programmes.烟草行业干扰烟草控制项目模式的发展
Tob Control. 2003 Jun;12(2):140-7. doi: 10.1136/tc.12.2.140.
4
Tobacco Institute lobbying at the state and local levels of government in the 1990s.20世纪90年代,烟草协会在州和地方政府层面进行游说活动。
Tob Control. 2002 Mar;11 Suppl 1(Suppl 1):I102-9. doi: 10.1136/tc.11.suppl_1.i102.
5
Tobacco lobby political influence on US state legislatures in the 1990s.20世纪90年代烟草游说团体对美国州立法机构的政治影响。
Tob Control. 2001 Jun;10(2):124-34. doi: 10.1136/tc.10.2.124.
6
Revealing and reversing tobacco industry strategies.揭示并扭转烟草行业的策略。
Am J Public Health. 1996 Aug;86(8):1073-5. doi: 10.2105/ajph.86.8_pt_1.1073.

本文引用的文献

1
The politics of antismoking legislation.反吸烟立法的政治因素
J Health Polit Policy Law. 1993 Winter;18(4):787-819.
2
Tobacco industry campaign contributions are affecting tobacco control policymaking in California.烟草行业的竞选捐款正在影响加利福尼亚州的烟草控制政策制定。
JAMA. 1994 Oct 19;272(15):1176-82.
3
Epidemiology of failed tobacco control legislation.烟草控制立法失败的流行病学研究。
JAMA. 1994 Oct 19;272(15):1171-5.
4
Legislating clean air. Politics, pre-emption, and the health of the public.制定清洁空气法规。政治、优先权与公众健康。
N C Med J. 1995 Jan;56(1):14-9.
5
The tobacco/health-insurance connection.烟草与健康保险的关联。
Lancet. 1995 Jul 8;346(8967):64. doi: 10.1016/s0140-6736(95)92104-4.
6
The tobacco industry provides a lesson in effective lobbying.烟草行业提供了一个有效游说的教训。
CMAJ. 1989 Aug 15;141(4):321-2.
7
The politics of local tobacco control.地方烟草控制政策
JAMA. 1991 Oct 16;266(15):2110-7.

美国的州烟草游说者和组织:越界了。

State tobacco lobbyists and organizations in the United States: crossed lines.

作者信息

Goldstein A O, Bearman N S

机构信息

Department of Family Medicine, University of North Carolina, Chapel Hill 27599-7595, USA.

出版信息

Am J Public Health. 1996 Aug;86(8):1137-42. doi: 10.2105/ajph.86.8_pt_1.1137.

DOI:10.2105/ajph.86.8_pt_1.1137
PMID:8712274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1380626/
Abstract

OBJECTIVES

This research took a quantitative look at state-level tobacco lobbying in the United States.

METHODS

Publicly available lobbying data were collected from all states during 1994. Data were compiled on tobacco industry lobbyists, their tobacco employers, health lobbyists, and factors associated with such lobbying.

RESULTS

In 1994, 450 tobacco industry lobbyists lobbied at a state level. Most lobbying was on behalf of four organizations: Philip Morris (34%), the Tobacco Institute (21%), RJ Reynolds (17%), and the Smokeless Tobacco Council (15%). Approximately one half of all tobacco lobbyists also lobbied for a health-related organization (e.g., state medical association, hospital, physician association).

CONCLUSIONS

All US states have tobacco lobbyists. Many health organizations knowingly or unknowingly employ lobbyists who also lobby for the tobacco industry.

摘要

目的

本研究对美国州一级的烟草游说活动进行了定量分析。

方法

收集了1994年所有州公开的游说数据。整理了烟草行业游说者、他们的烟草雇主、健康领域游说者以及与此类游说相关的因素的数据。

结果

1994年,有450名烟草行业游说者在州一级进行游说活动。大多数游说活动是代表四个组织进行的:菲利普·莫里斯公司(34%)、烟草协会(21%)、雷诺兹烟草公司(17%)和无烟烟草理事会(15%)。所有烟草游说者中约有一半还为与健康相关的组织(如州医学协会、医院、医师协会)进行游说。

结论

美国所有州都有烟草游说者。许多健康组织有意或无意地雇佣了也为烟草行业游说的游说者。